Organization

Dushu Lake Hospital Affiliated to Soochow University

2 clinical trials

1 abstract

Clinical trial
Allogenic B7H3-targeting CAR-γδT Cell Therapy in r/r GBM
Status: Recruiting, Estimated PCD: 2025-12-31
Abstract
Real-world data from a multi-center study: Insights to the efficacy and safety in patients with ovarian cancer (OC) received niraparib as first-line (1st-L) maintenance therapy (MT).
Org: Zhongda Hospital, Southeast University, School of Medicine, Zhejiang University, Hangzhou, China, University of Science and Technology of China, Fudan University (Xiamen Branch), Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research,